首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Journal of gastrointestinal oncology

缩写:

ISSN:2078-6891

e-ISSN:2219-679X

IF/分区:2.0/Q3

文章目录 更多期刊信息

共收录本刊相关文章索引116
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
Mario Anders,Eckart Frimberger,Simone Odau et al. Mario Anders et al.
Background: The evaluation of novel endoscopes may require testing in experimental tumor models, particularly when employing new biomarkers. Tumor models, however, exist almost exclusively in small animals. Therefore, we ...
Kinshuk Kumar,Corwyn Rowsell,Calvin Law et al. Kinshuk Kumar et al.
TThis paper reports two rare cases of patients with synchronous gastrointestinal stromal tumour (GIST) and colorectal adenocarcinoma (CRC) where adjuvant FOLFOX chemotherapy was administered concurrently with imatinib mesylate. The first ca...
Shane Hopkins,Gary Y Yang Shane Hopkins
Gastric cancer is a leading cause of cancer death worldwide. Complete resection offers the only chance for permanent control, and accurate staging and evaluation of treatment response are crucial for appropriate management. Positron Emissio...
John Y Nasr,Robert E Schoen John Y Nasr
Background: Barrett's esophagus with high grade dysplasia (HGD) may require surgical resection because of the risk of concomitant adenocarcinoma. The prevalence of invasive, occult carcinoma (≥stage 1B) in this setting h...
Jiezhong Chen,Xu-Feng Huang,Liang Qiao et al. Jiezhong Chen et al.
Introduction: Obesity is associated with poor prognosis of colon cancer and the mechanism for this is unknown. This study tested insulin-caused resistance to oxaliplatin via activation of PI3K/Akt pathway in HT29 cells. ...
Sezer Saglam,N Faruk Aykan,Burak Sakar et al. Sezer Saglam et al.
Background: Best response rates have been achieved with three-drug regimens containing 5-FU in the treatment of advanced gastric cancer (AGC) and oral fluoropyrimidines are the best alternatives as substitutes for infusio...